The National Institute for Health and Care Excellence (NICE) guidelines for the diagnosis and management of type 1 and type 2 diabetes in children and young people are currently under development with an intended completion date of August 2015. Information about this process is available here: http://guidance.nice.org.uk/CG/WaveR/118
Starship Children’s Health provides information and clinical guidelines on managing ketoacidosis in young people. They state, ‘diabetic ketoacidosis (DKA) is a life-threatening metabolic disorder resulting from decreased effective circulating insulin, insulin resistance and increased production of counter-regulatory hormones. The frequency of DKA ranges from
16–80% of children newly diagnosed with diabetes, depending on geographic location. It is the leading cause of morbidity and is the most common cause of diabetes-related deaths in children and adolescents with type 1 diabetes. Mortality is predominantly due to cerebral oedema which occurs in 0.3% to 1% of all episodes of diabetic ketoacidosis in children’.
Further information can be found at: www.starship.org.nz/media/273118/starship_dka_guideline_2014_v.2yellowhighlightsremovedtextboxes.pdf
